Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension

NCT: NCT01471834 · ACTIVE_NOT_RECRUITING

NCT IDNCT01471834
StatusACTIVE_NOT_RECRUITING
Start Date2011-06
Completion2026-12
SponsorCVRx, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.

Frequently Asked Questions

What is Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension?

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension is a clinical trial registered under NCT01471834. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT01471834?

The current status of NCT01471834 (Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension) is: ACTIVE_NOT_RECRUITING.

When did Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension start?

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension started on 2011-06.

Related Devices

PMA P180050Stimulator, carotid sinus nerveCvrx, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑